Stock price movements

A currency trader stands near screens showing the foreign exchange rates, left, at the foreign exchange dealing room in Seoul, South Korea, Monday, Sept. 23, 2019. Stocks got a downbeat start to the week as investors kept a wary eye on tensions with Iran and on signals from China and the U.S. on prospects for a resolution of their tariffs war. (AP Photo/Lee Jin-man)
September 23, 2019 - 1:07 am
BANGKOK (AP) — World shares were mostly lower Monday as investors kept a wary eye on tensions with Iran and on prospects for a resolution of the tariffs war between China and the U.S. Germany's DAX dropped 0.7% to 12,376.50 while the CAC 40 in Paris lost 0.5% to 5,662.00. Britain's FTSE 100 gave up...
Read More
This image provided on Sunday, Sept. 15, 2019, by the U.S. government and DigitalGlobe and annotated by the source, shows damage to the infrastructure at Saudi Aramco's Kuirais oil field in Buqyaq, Saudi Arabia. The drone attack Saturday on Saudi Arabia's Abqaiq plant and its Khurais oil field led to the interruption of an estimated 5.7 million barrels of the kingdom's crude oil production per day, equivalent to more than 5% of the world's daily supply. (U.S. government/Digital Globe via AP)
September 16, 2019 - 12:38 pm
WASHINGTON (AP) — The Latest on tensions in the Persian Gulf and the fallout after weekend attack on major oil sites in Saudi Arabia (all times local): 3:35 p.m. President Donald Trump says it's "looking like" Iran was responsible for the attacks on key oil installations in Saudi Arabia, but he...
Read More
People stand near an electronic stock board showing Japan's Nikkei 225 index at a securities firm in Tokyo Tuesday, Sept. 10, 2019. Asian shares were mixed Tuesday after a day of listless trading on Wall Street, as investors awaited signs on global interest rates.(AP Photo/Eugene Hoshiko)
September 10, 2019 - 1:29 am
TOKYO (AP) — Global shares were mixed Tuesday after a day of listless trading on Wall Street, as investors awaited signs on global interest rates. France's CAC 40 slipped 0.3% to 5,569.68 in early trading, while Germany's DAX fell 0.3% to 12,193.09. Britain's FTSE 100 inched down 0.1% to 7,228.18...
Read More
FILE - In this Nov. 6, 2007, file photo Patrick Byrne, President and CEO of Overstock.com is reflected on a large television screen while being interviewed at the headquarters for supporters of school vouchers in Salt Lake City. Byrne has resigned, saying he’d become “far too controversial” to helm the e-commerce company known for selling discounted sofas and jewelry. Bryne, who founded the online discount retailer 20 years ago, said Thursday, Aug. 22, 2019, that was “in the sad position” of having to step down. (AP Photo/Steve C. Wilson)
August 22, 2019 - 2:14 pm
SAN FRANCISCO (AP) — The CEO of Overstock.com has resigned, saying he'd become "far too controversial" to helm the e-commerce company known for selling discounted sofas and jewelry. Patrick Byrne's resignation Thursday came after the company issued a bizarre statement last week in which the former...
Read More
August 14, 2019 - 3:26 pm
OMAHA, Neb. (AP) — Billionaire Warren Buffett's company has been adding more Amazon shares to its investment cart. Berkshire Hathaway said in filings with the Securities and Exchange Commission on Wednesday that it owned 537,300 Amazon shares at the end of June, up from 483,300 shares. Buffett...
Read More
FILE - In this Sept. 21, 2016, file photo EpiPens that Mylan CEO Heather Bresch bought with her are seen on Capitol Hill in Washington as she testifies before the House Oversight Committee hearing on EpiPen price increases. Pfizer, the country's largest drugmaker, will absorb the generic pharmaceutical company Mylan, potentially creating a global generic powerhouse, the two companies said Monday, July 29, 2019. (AP Photo/Pablo Martinez Monsivais, File)
July 29, 2019 - 7:49 am
Pfizer, the country's largest drugmaker, is creating a hybrid new drug company by combining its off-patent branded drug business with the generic pharmaceutical company Mylan. The two companies said Monday that they'll ultimately spin off the combination of Mylan, a $10 billion company, with Pfizer...
Read More
FILE - This combination of April 30, 2018, file photos shows signage for a Sprint store in New York's Herald Square, top, and signage at a T-Mobile store in New York. Texas is joining more than a dozen states suing to stop T-Mobile’s $26.5 billion takeover of rival cellphone company Sprint, arguing that the deal is bad for consumers because it would reduce competition. (AP Photo/Bebeto Matthews, File)
July 26, 2019 - 2:09 pm
WASHINGTON (AP) — U.S. regulators have approved T-Mobile's $26.5 billion takeover of rival Sprint, despite fears of higher prices and job cuts, in a deal that would leave just three major cellphone companies in the country. Friday's approval from the Justice Department and five state attorneys...
Read More
July 09, 2019 - 1:05 am
BERLIN (AP) — Shares in Germany-based chemicals maker BASF have dropped after the company issued a profit warning, citing factors that included declining global auto production, weakness in the North American agricultural sector and trade conflicts. BASF shares dropped 5.1% to 59.38 euros ($66.62)...
Read More
Julie Wainwright, center, CEO of The RealReal, celebrates her company's IPO at the Nasdaq opening bell, Friday, June 28, 2019 in New York. The online reseller of luxury brand clothing and accessories is based in San Francisco. (AP Photo/Mark Lennihan)
June 28, 2019 - 8:05 am
NEW YORK (AP) — Shares of The RealReal jumped on their first day of trading Friday, as the secondhand-fashion online retailer tests investors' appetite for the staying power of online marketplaces for pre-owned discounted Gucci and other luxury goods. The San Francisco company, founded in 2011 by...
Read More
In this June 5, 2009, photo a woman has Botox injected at Reveal in Arlington, Va. AbbVie is buying Botox maker Allergan in a cash-and-stock deal the drugmakers value at around $63 billion. The maker of the blockbuster immune disorder treatment Humira said Tuesday, June 25, 2019, that it will pay $120.30 in cash and a portion of AbbVie stock for each Allergan share. (AP Photo/Jacquelyn Martin, File)
June 25, 2019 - 11:39 am
Facing competition for the world's top-selling drug, AbbVie is jumping on this year's pharmaceutical merger bandwagon with a $63 billion bid for Botox maker Allergan that's meant to spur future growth. Specialty drugmaker AbbVie said Tuesday that adding Allergan's aesthetics products and eye care...
Read More

Pages